Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

In Silico and In Vitro Studies of Mycotoxins and Their Cocktails; Their Toxicity and Its Mitigation by Silibinin Pre-Treatment

VN. Tran, J. Viktorova, K. Augustynkova, N. Jelenova, S. Dobiasova, K. Rehorova, M. Fenclova, M. Stranska-Zachariasova, L. Vitek, J. Hajslova, T. Ruml

. 2020 ; 12 (3) : . [pub] 20200228

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc21012848

Grant support
16-06008S Grantová Agentura České Republiky - International
18-00150S Grantová Agentura České Republiky - International
692195 Horizon 2020 - International
LTC19007 European Cooperation in Science and Technology - International
CZ.2.16/3.1.00/21537 and CZ.2.16/3.1.00/24503 Operational Programme Prague-Competitiveness - International
LO1601, MSMT-43760/2015 Czech National Program of Sustainability NPU I - International
AZV 16-27317A and RVO-VFN64165/2019 Ministerstvo Zdravotnictví Ceské Republiky - International

Mycotoxins found in randomly selected commercial milk thistle dietary supplement were evaluated for their toxicity in silico and in vitro. Using in silico methods, the basic physicochemical, pharmacological, and toxicological properties of the mycotoxins were predicted using ACD/Percepta. The in vitro cytotoxicity of individual mycotoxins was determined in mouse macrophage (RAW 264.7), human hepatoblastoma (HepG2), and human embryonic kidney (HEK 293T) cells. In addition, we studied the bioavailability potential of mycotoxins and silibinin utilizing an in vitro transwell system with differentiated human colon adenocarcinoma cells (Caco-2) simulating mycotoxin transfer through the intestinal epithelial barrier. The IC50 values for individual mycotoxins in studied cells were in the biologically relevant ranges as follows: 3.57-13.37 nM (T-2 toxin), 5.07-47.44 nM (HT-2 toxin), 3.66-17.74 nM (diacetoxyscirpenol). Furthermore, no acute toxicity was obtained for deoxynivalenol, beauvericin, zearalenone, enniatinENN-A, enniatin-A1, enniatin-B, enniatin-B1, alternariol, alternariol-9-methyl ether, tentoxin, and mycophenolic acid up to the 50 nM concentration. The acute toxicity of these mycotoxins in binary combinations exhibited antagonistic effects in the combinations of T-2 with DON, ENN-A1, or ENN-B, while the rest showed synergistic or additive effects. Silibinin had a significant protective effect against both the cytotoxicity of three mycotoxins (T-2 toxin, HT-2 toxin, DAS) and genotoxicity of AME, AOH, DON, and ENNs on HEK 293T. The bioavailability results confirmed that AME, DAS, ENN-B, TEN, T-2, and silibinin are transported through the epithelial cell layer and further metabolized. The bioavailability of silibinin is very similar to mycotoxins poor penetration.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012848
003      
CZ-PrNML
005      
20210507104938.0
007      
ta
008      
210420s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/toxins12030148 $2 doi
035    __
$a (PubMed)32121188
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Tran, Van Nguyen $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technicka 3, 16628 Prague 6, Czech Republic
245    10
$a In Silico and In Vitro Studies of Mycotoxins and Their Cocktails; Their Toxicity and Its Mitigation by Silibinin Pre-Treatment / $c VN. Tran, J. Viktorova, K. Augustynkova, N. Jelenova, S. Dobiasova, K. Rehorova, M. Fenclova, M. Stranska-Zachariasova, L. Vitek, J. Hajslova, T. Ruml
520    9_
$a Mycotoxins found in randomly selected commercial milk thistle dietary supplement were evaluated for their toxicity in silico and in vitro. Using in silico methods, the basic physicochemical, pharmacological, and toxicological properties of the mycotoxins were predicted using ACD/Percepta. The in vitro cytotoxicity of individual mycotoxins was determined in mouse macrophage (RAW 264.7), human hepatoblastoma (HepG2), and human embryonic kidney (HEK 293T) cells. In addition, we studied the bioavailability potential of mycotoxins and silibinin utilizing an in vitro transwell system with differentiated human colon adenocarcinoma cells (Caco-2) simulating mycotoxin transfer through the intestinal epithelial barrier. The IC50 values for individual mycotoxins in studied cells were in the biologically relevant ranges as follows: 3.57-13.37 nM (T-2 toxin), 5.07-47.44 nM (HT-2 toxin), 3.66-17.74 nM (diacetoxyscirpenol). Furthermore, no acute toxicity was obtained for deoxynivalenol, beauvericin, zearalenone, enniatinENN-A, enniatin-A1, enniatin-B, enniatin-B1, alternariol, alternariol-9-methyl ether, tentoxin, and mycophenolic acid up to the 50 nM concentration. The acute toxicity of these mycotoxins in binary combinations exhibited antagonistic effects in the combinations of T-2 with DON, ENN-A1, or ENN-B, while the rest showed synergistic or additive effects. Silibinin had a significant protective effect against both the cytotoxicity of three mycotoxins (T-2 toxin, HT-2 toxin, DAS) and genotoxicity of AME, AOH, DON, and ENNs on HEK 293T. The bioavailability results confirmed that AME, DAS, ENN-B, TEN, T-2, and silibinin are transported through the epithelial cell layer and further metabolized. The bioavailability of silibinin is very similar to mycotoxins poor penetration.
650    _2
$a P-glykoprotein $x metabolismus $7 D020168
650    _2
$a zvířata $7 D000818
650    _2
$a buněčné linie $7 D002460
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a kokultivační techniky $7 D018920
650    _2
$a kometový test $7 D020552
650    _2
$a počítačová simulace $7 D003198
650    _2
$a potravní doplňky $7 D019587
650    _2
$a lékové interakce $7 D004347
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a ostropestřec mariánský $x chemie $7 D020944
650    _2
$a mykotoxiny $x toxicita $7 D009183
650    _2
$a ochranné látky $x farmakologie $7 D020011
650    _2
$a silibinin $x farmakologie $7 D000077385
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Viktorova, Jitka $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technicka 3, 16628 Prague 6, Czech Republic
700    1_
$a Augustynkova, Katerina $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technicka 3, 16628 Prague 6, Czech Republic
700    1_
$a Jelenova, Nikola $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technicka 3, 16628 Prague 6, Czech Republic
700    1_
$a Dobiasova, Simona $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technicka 3, 16628 Prague 6, Czech Republic
700    1_
$a Rehorova, Katerina $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technicka 3, 16628 Prague 6, Czech Republic
700    1_
$a Fenclova, Marie $u Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technicka 3, 16628 Prague 6, Czech Republic
700    1_
$a Stranska-Zachariasova, Milena $u Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technicka 3, 16628 Prague 6, Czech Republic
700    1_
$a Vitek, Libor $u First Faculty of Medicine, Charles University, Katerinska 32, 12108 Prague 2, Czech Republic $u Faculty General Hospital, U Nemocnice 2, 12808 Praha 2, Czech Republic
700    1_
$a Hajslova, Jana $u Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technicka 3, 16628 Prague 6, Czech Republic
700    1_
$a Ruml, Tomas $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technicka 3, 16628 Prague 6, Czech Republic
773    0_
$w MED00177194 $t Toxins $x 2072-6651 $g Roč. 12, č. 3 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32121188 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507104936 $b ABA008
999    __
$a ok $b bmc $g 1651092 $s 1133227
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 12 $c 3 $e 20200228 $i 2072-6651 $m Toxins $n Toxins $x MED00177194
GRA    __
$a 16-06008S $p Grantová Agentura České Republiky $2 International
GRA    __
$a 18-00150S $p Grantová Agentura České Republiky $2 International
GRA    __
$a 692195 $p Horizon 2020 $2 International
GRA    __
$a LTC19007 $p European Cooperation in Science and Technology $2 International
GRA    __
$a CZ.2.16/3.1.00/21537 and CZ.2.16/3.1.00/24503 $p Operational Programme Prague-Competitiveness $2 International
GRA    __
$a LO1601, MSMT-43760/2015 $p Czech National Program of Sustainability NPU I $2 International
GRA    __
$a AZV 16-27317A and RVO-VFN64165/2019 $p Ministerstvo Zdravotnictví Ceské Republiky $2 International
LZP    __
$a Pubmed-20210420

Find record

Citation metrics

Logged in users only

Archiving options